Rapid HPLC-Electrospray Tandem Mass Spectrometric Assay for Urinary Testosterone and Dihydrotestosterone Glucuronides from Patients with Benign Prostate Hyperplasia
- 1 February 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 49 (2) , 322-325
- https://doi.org/10.1373/49.2.322
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Measurement of corticoids in the patients with clinical features indicative of mineralocorticoid excessClinica Chimica Acta; International Journal of Clinical Chemistry, 2002
- 5α-reductase activity in the prostateUrology, 2001
- Biochemical Roles of Testosterone and Epitestosterone to 5α-Reductase as Indicators of Male-Pattern BaldnessJournal of Investigative Dermatology, 2001
- Simultaneous determination of urinary androgen glucuronides by high temperature gas chromatography-mass spectrometry with selected ion monitoringSteroids, 2000
- A new method for hydrolyzing sulfate and glucuronyl conjugates of steroidsAnalytical Biochemistry, 1989
- Simultaneous Determination of Testosterone, Dihydrotestosterone and 5α‐Androstan‐3α,‐17β‐Diol by Isotopic Dilution Mass Spectrometry in Plasma and Prostatic Tissue of Patients Affected by Benign Prostatic Hyperplasia Effects of 3‐Month Treatment with a GnRH AnalogJournal of Andrology, 1988
- Decreased Urinary 5a-Androstane-3α,17β-Diol Glucuronide Excretion in Patients with Benign Prostatic Hyperplasia*Journal of Clinical Endocrinology & Metabolism, 1985
- The pathogenesis of benign prostatic hyperplasiaThe American Journal of Medicine, 1980
- The induction of prostatic hypertrophy in the dog with androstanediol.Journal of Clinical Investigation, 1976
- ALTERED BLOOD ANDROGENS IN ELDERLY MEN WITH PROSTATE HYPERPLASIA.Journal of Clinical Endocrinology & Metabolism, 1975